Luigi Marino

Dr. Luigi Marino is an ophthalmologist at the Casa di Cura La Madonnina in Milan, Italy.

Graduated with honors from the University of Florence (Università degli Studi di Firenze) with a degree in Medicine and Surgery in 1983. In 1987 finished a program of specialization in ophthalmology, also with honors, at the University of Bari (Università degli Studi di Bari).

From the beginning of his university studies, Dr. Marino was interested in experimental surgery with the therapeutic use of the first lasers. In 1988 he received his Ph.D. from the Barraquer Institute at the Autonomous University of Barcelona. In 1995 and 2004 he completed the Master programs at the SDA School of Management of the Luigi Bocconi University in Milan.

Dr. Marino is a recognized expert in laser refractive surgery, in particular within the use of:

• femtosecond laser,
• excimer laser,
• Relex smile Zeiss.

Dr. Marino has received numerous awards for his contributions to the ophthalmology field and holds the following positions:

• Director of the European Dry Eye Institute;
• University professor;
• UN consultant in Geneva;
• one of the founders of the Italian Association of Ophthalmologists (AIMO);
• member of the American Academy of Ophthalmology, ESCRS, ASCRS, SIOL, SIOT;
• secretary of the Italian Society of Laser Ophthalmology (SILO);
• an ophthalmologist of A.C. Milan and FISI (Italian Winter Sports Federation);
• consultant to the Chamber of Deputies during the Legislature XVII of the Italian Republic.

Dr. Marino is also the recipient of numerous scientific and research merit awards:

• Prize of the Italian Ophthalmological Society (1988, 1995, 2003);
• Prize of the Italian Society of Laser in Ophthalmology (2004);
• Gold Medal of the Order of Saint Maurizio conferred by the President of the Italian Republic (2006).

Dr. Marino is currently interested in the possibilities of new generation lasers for vitreolysis, low-threshold lasers, femtolaser for cataract and refractive surgery, pulsed light for the treatment of the dry eye syndrome.

Participates in clinical trials of various classes of ophthalmic drugs, such as chemotherapy, antibiotics and antiangiogenic agents, artificial tears, immunomodulators, NGF (Nerve Growth Factor).

Dr. Marino collaborates with international research centers for the treatment of dry eye syndrome. He is a speaker and organizer of numerous national and international conferences.